Lixte Biotechnology Holdings Inc

Market Cap

$89M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$7.00+$3.16 (+82.29%)

Jun 5, 2026

52W High $7.2152W Low $0.71

Company Details

Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product cand...

CEO

—

IPO Date

Sep 21, 2007

Website

lixte.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$7M

EPS (Diluted)

Free Cash Flow

-$4M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 14, 2026

FY 2025

Mar 31, 2026

Q4 2025

Mar 31, 2026

Q3 2025

Nov 12, 2025

Q2 2025

Aug 7, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee